Home › Funds › Vanguard Group › BBIO
Vanguard Group position in BBIO
BRIDGEBIO PHARMA INC · Health Care
Latest position (Q4 2025)16.86M sh
Reported value held$1.29B
Portfolio Weight0.02%
First reportedQ1 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2021 | 9.34M | $575.42M | New |
| Q2 2021 | 11.33M | $690.62M | Add |
| Q3 2021 | 9.44M | $442.24M | Reduce |
| Q4 2021 | 9.33M | $155.65M | Reduce |
| Q1 2022 | 9.42M | $95.66M | Add |
| Q2 2022 | 9.90M | $89.85M | Add |
| Q3 2022 | 10.00M | $99.44M | Add |
| Q4 2022 | 10.59M | $80.71M | Add |
| Q1 2023 | 12.06M | $200.01M | Add |
| Q2 2023 | 11.68M | $200.98M | Reduce |
| Q3 2023 | 11.28M | $297.35M | Reduce |
| Q4 2023 | 12.80M | $516.75M | Add |
| Q1 2024 | 13.22M | $408.83M | Add |
| Q2 2024 | 14.05M | $356.01M | Add |
| Q3 2024 | 14.20M | $361.50M | Add |
| Q4 2024 | 15.08M | $413.74M | Add |
| Q1 2025 | 14.90M | $515.10M | Reduce |
| Q2 2025 | 16.48M | $711.82M | Add |
| Q3 2025 | 16.83M | $874.26M | Add |
| Q4 2025 | 16.86M | $1.29B | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BBIO
- Janus Henderson Group 13.18M sh · $978.61M · Q1 2026
- Farallon Capital Management 10.74M sh · $800.14M · Q2 2026
- Viking Global Investors 9.95M sh · $741.02M · Q2 2026
- Two Sigma Investments 4.75M sh · $353.43M · Q2 2026
- D. E. Shaw & Co 3.66M sh · $272.89M · Q2 2026
- Geode Capital Management 3.42M sh · $254.67M · Q2 2026
- Manulife Financial 1.96M sh · $145.66M · Q2 2026
- Charles Schwab Investment Management 1.71M sh · $127.32M · Q2 2026
- Norges Bank Investment Management 1.69M sh · $126.15M · Q2 2026
- Morgan Stanley 1.69M sh · $126.14M · Q2 2026
- Point72 Asset Management 1.53M sh · $114.16M · Q2 2026